相关实验视频
Updated: Jul 19, 2026

09:34
In Vivo Canine Muscle Function Assay
Published on: April 5, 2011
中性内酶在患有正在演变的充血性心力衰竭的狗中的作用
K B Margulies1, P L Barclay, J C Burnett
1Section of Cardiology, Temple University School of Medicine, Philadelphia, Pa 19140.
Circulation
|April 1, 1995
概括
中性内皮酶抑制 (NEP-I) 在充血性心力衰竭 (CHF) 中增强脏对心房性尿素因子 (ANF) 的反应. 这种策略可以改善平衡,但不能完全解决CHF发展中的保留问题.
科学领域:
- 心血管生理学心血管生理学
- 脏生理学 脏生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 充血性心力衰竭 (CHF) 涉及神经性功能障碍,包括脏对心房性尿素因子 (ANF) 的反应减少.
- 中性内皮酶24.11 (NEP) 降解ANF,其活性可能在CHF中增加,导致保留.
- 针对NEP可以增强ANF的效果,并减轻CHF的进展.
研究的目的:
- 调查慢性中性内酶抑制 (NEP-I) 对ANF的脏反应的影响,在不断发展的充血性心力衰竭 (CHF) 的动物模型中.
- 为了确定NEP-I是否会在慢性心脏病的进展过程中改变保留和脏周期性瓜诺辛单酸盐 (cGMP) 生产.
主要方法:
- 利用13只有意识的狗患有心室节奏诱导的进化性心脏不全症.
- 在整个研究过程中,口服给六只狗使用康多克萨特里尔 (NEP-I).
- 在基线和CHF6天后对外源ANF (10微克/千克IV玻尿酸) 的评估反应.
- 进行了每日代谢研究,并测量了脏cGMP生成.
主要成果:
- 慢性NEP-I增强脏分泌和cGMP生成在狗进化的CHF,表明内源性ANF的活动增加.
- 对外源性ANF的脏尿剂和cGMP反应在CHF中与NEP-I保持不变,与未治疗的CHF反应减弱的不同.
- 尽管改善了ANF响应和平衡,但在慢性NEP-I期间,在不断发展的CHF中,中等程度的保留仍然存在.
结论:
- 通过NEP的酶降解限制了CHF中的脏ANF反应,无论系统血液动力学或ANF血水平如何.
- 在CHF中,NEP-I增强了脏对内源和外源ANF的反应.
- 尽管NEP-I存在,但CHF中持续的保留表明其他ANF独立的抗尿素因子的贡献.
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

